Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec:170:108502.
doi: 10.1016/j.diabres.2020.108502. Epub 2020 Oct 13.

Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology

Rodolfo J Galindo  1 , Grazia Aleppo  2
Affiliations
Review

Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology

Rodolfo J Galindo et al. Diabetes Res Clin Pract. 2020 Dec.

Abstract

Monitoring of glucose levels is essential to effective diabetes management. Over the past 100 years, there have been numerous innovations in glucose monitoring methods. The most recent advances have centered on continuous glucose monitoring (CGM) technologies. Numerous studies have demonstrated that use of continuous glucose monitoring confers significant glycemic benefits on individuals with type 1 diabetes (T1DM) and type 2 diabetes (T2DM). Ongoing improvements in accuracy and convenience of CGM devices have prompted increasing adoption of this technology. The development of standardized metrics for assessing CGM data has greatly improved and streamlined analysis and interpretation, enabling clinicians and patients to make more informed therapy modifications. However, many clinicians many be unfamiliar with current CGM and how use of these devices may help individuals with T1DM and T2DM achieve their glycemic targets. The purpose of this review is to present an overview of current CGM systems and provide guidance to clinicians for initiating and utilizing CGM in their practice settings.

Keywords: AGP; Ambulatory Glucose Profile; CGM; Continuous glucose monitoring; HbA1c; Intermittently scanned CGM; Real-time CGM; Type 1 diabetes; Type 2 diabetes; isCGM; rtCGM.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: RJG has received unrestricted research support to Emory for investigator-initiated studies from Novo Nordisk and Dexcom INC, and consulting fees from Abbott Diabetes Care, Sanofi, Novo Nordisk, Eli Lilly, and Valeritas. RJG is partially supported by research grants from NIH/NIDDK P30DK111024 and 1K23DK123384-01. GA has received research support from AstraZeneca, Dexcom, Eli Lilly, Insulet, Novo Nordisk, and is a consultant for Dexcom and Insulet.

Figures

Figure 1.
Figure 1.
Ambulatory Glucose Profile (AGP)
See this image and copyright information in PMC

References

    1. Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA 2017; 317:371–378. - PubMed
    1. Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med 2017;167:365–374. - PubMed
    1. Šoupal J, Petruželková L, Grunberger G, et al. Glycemic Outcomes in Adults with T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up from The COMISAIR Study. Diabetes Care 2020. January; 43(1): 37–43. - PubMed
    1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016;388:2254–2263. - PubMed
    1. Haak T, Hanaire H, Ajjan R, et al.: Use of flash glucose sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. Diabetes Ther 2017;8:573–586. - PMC - PubMed

MeSH terms